Bunsua, Merly L.
HRN: 29-05-76 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2026
05/29/2026
IVTT
4.5
Q8H
INFECTED WOUND
Checking Initial Appropriateness
05/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/22/2026
05/29/2026
IVTT
600mg
Q8H
Infected Wound
Checking Initial Appropriateness
06/20/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/20/2026
06/27/2026
IV
1.5g
Q6hrs
Breast Mass Left
Checking Initial Appropriateness
06/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2026
06/27/2026
IV
600mg
Q6hrs
Breast Mass Left
Checking Initial Appropriateness